HKD 1.03
(-1.9%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 847.78 Million CNY | -15.92% |
2022 | 1 Billion CNY | -3.2% |
2021 | 1.04 Billion CNY | -7.78% |
2020 | 1.12 Billion CNY | -12.04% |
2019 | 1.28 Billion CNY | 1345.82% |
2018 | 88.81 Million CNY | -45.05% |
2017 | 161.63 Million CNY | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 841.8 Million CNY | 0.0% |
2023 FY | 847.78 Million CNY | -15.92% |
2023 Q4 | 847.78 Million CNY | 0.0% |
2023 Q2 | 907.38 Million CNY | 0.0% |
2022 Q2 | 922.11 Million CNY | 0.0% |
2022 FY | 1 Billion CNY | -3.2% |
2022 Q4 | 1 Billion CNY | 0.0% |
2021 FY | 1.04 Billion CNY | -7.78% |
2021 Q4 | 1.04 Billion CNY | 0.0% |
2021 Q2 | 1.03 Billion CNY | 0.0% |
2020 FY | 1.12 Billion CNY | -12.04% |
2020 Q2 | 1.22 Billion CNY | 0.0% |
2020 Q4 | 1.12 Billion CNY | 0.0% |
2019 Q1 | 246.88 Million CNY | 0.0% |
2019 FY | 1.28 Billion CNY | 1345.82% |
2019 Q4 | 1.28 Billion CNY | 0.0% |
2018 FY | 88.81 Million CNY | -45.05% |
2017 FY | 161.63 Million CNY | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Uni-Bio Science Group Limited | 409.99 Million HKD | -106.781% |
CK Life Sciences Int'l., (Holdings) Inc. | 11.24 Billion HKD | 92.462% |